Chloe Stengel

601 total citations
13 papers, 482 citations indexed

About

Chloe Stengel is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Chloe Stengel has authored 13 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Chloe Stengel's work include Enzyme function and inhibition (4 papers), Cancer Mechanisms and Therapy (3 papers) and Estrogen and related hormone effects (3 papers). Chloe Stengel is often cited by papers focused on Enzyme function and inhibition (4 papers), Cancer Mechanisms and Therapy (3 papers) and Estrogen and related hormone effects (3 papers). Chloe Stengel collaborates with scholars based in United Kingdom, France and Italy. Chloe Stengel's co-authors include Michael Reed, Mathew P. Leese, B. V. L. POTTER, Stephen T. Newman, A. Purohit, Atul Purohit, Simon P. Newman, Paul Foster, Barry V. L. Potter and Reto Neiger and has published in prestigious journals such as Chemical Communications, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Chloe Stengel

13 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chloe Stengel United Kingdom	11	271	180	113	110	73	13	482
Czesław Radzikowski Poland	14	338 1.2×	130 0.7×	99 0.9×	63 0.6×	99 1.4×	28	533
Toshiyasu Ishioka Japan	8	299 1.1×	169 0.9×	95 0.8×	62 0.6×	22 0.3×	11	585
Thierry Louat Belgium	14	347 1.3×	114 0.6×	75 0.7×	97 0.9×	49 0.7×	22	617
Diana C. West United States	9	292 1.1×	98 0.5×	146 1.3×	84 0.8×	21 0.3×	10	525
Shuyun Rao United States	13	526 1.9×	44 0.2×	157 1.4×	47 0.4×	40 0.5×	24	722
Sueo Mukumoto Japan	8	310 1.1×	61 0.3×	120 1.1×	54 0.5×	17 0.2×	9	495
Toshihiro Chikanishi Japan	10	337 1.2×	104 0.6×	37 0.3×	24 0.2×	21 0.3×	12	504
Nilesh Zaware United States	12	463 1.7×	141 0.8×	102 0.9×	16 0.1×	27 0.4×	19	625
Brian Zifcak United States	7	431 1.6×	125 0.7×	136 1.2×	16 0.1×	31 0.4×	10	570
Paul Kwon United States	7	657 2.4×	78 0.4×	169 1.5×	42 0.4×	34 0.5×	9	728

Countries citing papers authored by Chloe Stengel

Since Specialization

Citations

This map shows the geographic impact of Chloe Stengel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloe Stengel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloe Stengel more than expected).

Fields of papers citing papers by Chloe Stengel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloe Stengel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloe Stengel. The network helps show where Chloe Stengel may publish in the future.

Co-authorship network of co-authors of Chloe Stengel

This figure shows the co-authorship network connecting the top 25 collaborators of Chloe Stengel. A scholar is included among the top collaborators of Chloe Stengel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloe Stengel. Chloe Stengel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Stengel, Chloe, Simon P. Newman, Mathew P. Leese, et al.. (2015). The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX Expression.. PubMed. 35(10). 5249–61. 11 indexed citations

Meja, Koremu, Chloe Stengel, Rob S. Sellar, et al.. (2014). PIM and AKT kinase inhibitors show synergistic cytotoxicity in acute myeloid leukaemia that is associated with convergence on mTOR and MCL1 pathways. British Journal of Haematology. 167(1). 69–79. 44 indexed citations

Stengel, Chloe, Stephen T. Newman, Joanna M. Day, et al.. (2014). In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer. British Journal of Cancer. 111(2). 300–308. 11 indexed citations

Stengel, Chloe, et al.. (2012). Dietary hyperthyroidism in dogs. Journal of Small Animal Practice. 53(3). 182–184. 39 indexed citations

Stengel, Chloe, et al.. (2012). Optimal induction of myeloma cell death requires dual blockade of phosphoinositide 3-kinase and mTOR signalling and is determined by translocation subtype. Leukemia. 26(8). 1761–1770. 18 indexed citations

Glassford, Janet, Deepika Kassen, Jean A. Quinn, et al.. (2012). Inhibition of cell cycle progression by dual phosphatidylinositol-3-kinase and mTOR blockade in cyclin D2 positive multiple myeloma bearing IgH translocations. Blood Cancer Journal. 2(1). e50–e50. 10 indexed citations

Leese, Mathew P., Fabrice Jourdan, Gyles E. Cozier, et al.. (2010). Chimeric microtubule disruptors. Chemical Communications. 46(17). 2907–2907. 25 indexed citations

Stengel, Chloe, Stephen T. Newman, Mathew P. Leese, et al.. (2009). Class III β-tubulin expression and in vitro resistance to microtubule targeting agents. British Journal of Cancer. 102(2). 316–324. 167 indexed citations

Leese, Mathew P., Fabrice Jourdan, Keira Gaukroger, et al.. (2008). Structure–Activity Relationships of C-17 Cyano-Substituted Estratrienes as Anticancer Agents. Journal of Medicinal Chemistry. 51(5). 1295–1308. 49 indexed citations

10.

Foster, Paul, Chloe Stengel, Mathew P. Leese, et al.. (2008). A comparison of two orally bioavailable anti-cancer agents, IRC-110160 and STX140.. PubMed. 28(3A). 1483–91. 9 indexed citations

11.

Newman, Simon P., Paul Foster, Chloe Stengel, et al.. (2008). STX140 Is Efficacious In vitro and In vivo in Taxane-Resistant Breast Carcinoma Cells. Clinical Cancer Research. 14(2). 597–606. 41 indexed citations

12.

Stengel, Chloe, Simon P. Newman, Joanna M. Day, et al.. (2007). Effects of mutations and glycosylations on STS activity: A site-directed mutagenesis study. Molecular and Cellular Endocrinology. 283(1-2). 76–82. 7 indexed citations

13.

Foster, Paul, Simon P. Newman, Surinder K. Chander, et al.. (2006). In vivo Efficacy of STX213, A Second-Generation Steroid Sulfatase Inhibitor, for Hormone-Dependent Breast Cancer Therapy. Clinical Cancer Research. 12(18). 5543–5549. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact